Objective: To compare the association of obesity and abdominal obesity with cardiometabolic risk factor burden and global estimated coronary heart disease (CHD) risk among multiethnic US adults. Design: Cross-sectional, survey study. Results: Overall, abdominal obesity was present in 42.3% of men and 62.5% of women and in 53.6% of whites, 56.9% of blacks and 50.5% of Hispanics (Po0.001 between gender and ethnicity). However, using International Diabetes Federation (IDF)-recommended WC cut points for Hispanics, the prevalence of abdominal obesity was 78.3%. Mean levels of low-density lipoprotein cholesterol (LDL-C), systolic and diastolic blood pressure, fasting glucose and C-reactive protein increased, and highdensity lipoprotein cholesterol (HDL-C) decreased (Po0.001) according to BMI and WC categories, although these associations were attenuated in blacks for blood pressure, LDL-C, HDL-C and triglycerides. Of those with high WC, 25-35% had X3 cardiometabolic risk factors. High CHD risk among those with high WC was most common in men (27.9%) and non-Hispanic whites (23.9%). Persons with a high vs normal WC, adjusted for age, gender, ethnicity and BMI were more likely to have X3 cardiometabolic risk factors (odds ratio (OR) ¼ 5.1, 95% confidence interval (CI) ¼ 3.9-6.6) and were classified as high CHD risk (OR ¼ 1.5, 95% CI ¼ 1.1-2.0). Conclusion: The association of abdominal obesity with risk factors varies by ethnicity and is independently associated with high CHD risk status, further validating its clinical significance.
Introduction
There has been a dramatic increase in the prevalence of obesity in US adults over the past half century. Obesity is a well-recognized risk factor for cardiovascular disease (CVD) and diabetes, and is closely associated with other risk factors including hypertension, dyslipidemia and systemic inflammation. 1 In addition, the extent and prevalence of abdominal obesity (defined as waist circumference (WC) 4102 cm in men and 488 cm in women among US adults 2 ) have also increased over recent decades. Recently published data on US adults show increases, during 1988-1994 and 2003-2004 , in mean WC of 96.0-100.4 cm among men and 89.0-94.0 cm among women, with corresponding increases in the prevalence of abdominal obesity of 29.5-42.4% among men and 47.0-61.3% among women across the same time period (all Po0.001). 3 Moreover, recent recommendations by the International Diabetes Federation (IDF) 4 have indicated lower cut points to define abdominal obesity among European Caucasians and other ethnic groups, including Asians and Hispanics, highlighting this to be an emerging global epidemic. These substantial increases in obesity, also closely linked to insulin resistance and cardiometabolic risk, 1, 3 have motivated the development of therapies aimed to target obesity and its associated risk factors. Not well understood, however, is the current extent of cardiometabolic risk factor burden associated with abdominal obesity among a recent US representative cohort of adults, in particular among the major ethnic groups represented in the United States. Although obesity is closely associated with dyslipidemia, hypertension and diabetes/impaired fasting glucose, as well as inflammation, 1 the extent to which these abnormalities vary with the extent of overweight/obesity has not been described in a population representative sample of the US adults. Moreover, the extent of global risk for coronary heart disease (CHD) associated with differing degrees of overweight/obesity is not well described. This project proposes to characterize among a recent representative multiethnic cohort of US adults in the 2003-2004 National Health and Nutrition Examination Survey (NHANES) the prevalence of obesity vs abdominal obesity and the extent of cardiometabolic risk factors and estimated global risk of CHD according to the level of obesity, specifically in relation to abdominal obesity.
Research methods and procedures
The sample population consists of the US adults aged 20-79 years from the NHANES 2003-2004 with measures of body mass index (BMI) and WC. The NHANES is a nationally representative cross-sectional survey of all US noninstitutionalized adults and includes individual-reported demographic and socioeconomic information as well as medical examination data, physiological measurements and laboratory tests results. The methods and procedures have been described previously.
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Measurements and definitions Abdominal obesity was defined by WC measurements 488 cm in women and 4102 cm in men. 2 For Hispanics, we have also included analyses performed according to IDF-recommended WC cut points of 480 cm in women and 490 cm in men to define abdominal obesity. 4 These lower cut points are only applicable to Hispanics in our sample, as NHANES did not have Asian subgroups defined (where lower WC cut points would also apply), and the higher previously mentioned WC cut points are still recommended by IDF to be used in Caucasians living in the United States. CVD was defined on the basis of self-report of myocardial infarction, stroke, congestive heart failure, CHD, or additionally by an ankle brachial index of o0.9, indicative of peripheral artery disease. Diabetes was also defined by selfreport or a measured fasting glucose of 7.0 mmol l
À1
(X126 mg 100 ml ), or by the use of an oral hypoglycemic medication or insulin. Hypertension was defined as blood pressure levels X140 mm Hg systolic or X90 mm Hg diastolic or on antihypertensive medications. Elevated high sensitivity C-reactive protein was defined as 43 mg l À1 according to current recommendations. 6 Elevated low-density lipoprotein cholesterol (LDL-C) levels were consistent with the guidelines of the National Cholesterol Education Program Adult Treatment Panel lll, that is, 4.2 mmol l À1 (X160 mg 100 ml
) among individuals with less than two risk factors, 3.4 mmol l À1 (X130 mg 100 ml
) among those with two or more risk factors and 2.6 mmol l À1 (X100 mg 100 ml
) among those with two or more risk factors in addition to a 10-year risk of CHD of 420% on the basis of the Framingham risk scoring or with preexisting CVD or diabetes. 7 These risk factors included age (X45 years in men and X55 years in women 8 ), high-density lipoprotein cholesterol (HDL-C) 1.0 mmol l À1 (440 mg 100 ml À1 ; regardless of gender), hypertension, current smoking and family history of heart attack with HDL-C levels of 1.6 mmol l
(460 mg 100 ml
) as a negative risk factor. Overall, low HDL-C was defined as 1.0 mmol l À1 (o40 mg 100 ml
) in men and 1.3 mmol l À1 (o50 mg 100 ml
) in women and elevated triglyceride levels were 3.9 mmol l À1 (X150 mg 100 ml
).
Statistical analysis
The proportion of individuals (by gender, ethnicity and age group) within each obesity and abdominal obesity group was calculated. We also examined the prevalence of abdominal obesity across BMI groups using the w 2 -test of proportions.
Gender stratified analyses of the prevalence and mean number of cardiometabolic risk factors within each obesity and abdominal obesity group were performed. Also, the distribution of Framingham risk score 5 (low ¼ o6%, moderate ¼ 5-o10%, moderately high ¼ 10-p20% and high ¼ 420%) by obesity and abdominal obesity group was also presented. Cross-tabulation procedures with SUDAAN statistical software version 9.0.1 (Research Triangle Park, NC, USA) were used for population-weighted percentages. 9 The w 2 -test of proportions was used to compare the proportion of subjects and the prevalence of cardiometabolic risk factors in each BMI and WC group according to gender, ethnicity and age group. Analysis of variance was used to compare mean levels of cardiometabolic risk factors in BMI and WC groups in the overall sample and stratified by ethnicity. Finally, multiple logistic regressions examined the relationship of obesity and abdominal obesity categories (lowest category being the reference category) with the likelihood of having multiple (X3) risk factors or high CVD risk status (defined as having either CVD as defined above, diabetes or 420% 10-year Framingham risk of CHD). The a-probability level for statistical analyses was set to 0.05. These analyses were conducted for the overall sample and stratified by ethnicity. SAS statistical software version 9.1.3 (SAS Institute, Cary, NC, USA) 10 as well as SUDAAN software were used for the analysis and computation of weighted estimates for projection to the population of the United States. ) groups (Po0.001 comparing men and women across BMI groups), a significantly higher proportion of women compared with men were defined as abdominally obese (62.5 vs 42.3%, Po0.001). Moreover, non-Hispanic blacks and Hispanics tended to have the highest prevalence of obesity defined by BMI categories (Po0.001 across ethnic groups), although the abdominal obesity was highest in non-Hispanic whites and blacks (Po0.001 across ethnic groups). Using the lower IDF-recommended cut points for Hispanics, the prevalence of abdominal obesity was much higher at 78.3%, including 71.9% in men and 84.6% in women. There was also an increasing prevalence of obesity and abdominal obesity by age group (Po0.001 across age groups).
Examination of the relation of BMI group with WC in the overall sample shows the prevalence of increased WC to increase dramatically with BMI group (o18.5, 18.5-o25, 25-o30, 30-o35 and X35 kg/m 2 ), with a higher prevalence in the middle categories in women (3.67, 15.8, 81.3, 99.4 and 100%, respectively) than in men (0, 1.2, 35.1, 89.0 and 100%, respectively). Moreover, the prevalence of high WC was highest among non-Hispanic whites (2.9, 10.4, 59.0, 95.9 and 100%, respectively). Using IDF-recommended cut points for Hispanics, the prevalence of abdominal obesity is essentially universal, once BMI reaches 25 kg/m 2 (0, 34.3, 91.6, 100 and 100%, respectively; Data not shown). Table 2 shows mean levels of selected cardiometabolic risk factors in BMI and WC category overall and by ethnicity. Both mean levels of systolic and diastolic blood pressure, LDL-C, triglycerides, fasting glucose and C-reactive protein increased substantially across BMI as well as WC categories (all Po0.001), and HDL-C decreased significantly (Po0.001). Noteworthy is that fasting triglycerides were more than twofold greater in those with BMI 435 vs o18.5 kg/m 2 (155.6 vs 73.6 mg 100 ml
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À1
) and C-reactive protein approximately fourfold higher (4.3 vs 1.1 mg l
). With the exception of family history of CHD, the prevalence of all risk factors dramatically increased from the lowest to the highest BMI category (data not shown), often by fivefold or greater (Po0.01-Po0.001). Most notable were elevated C-reactive protein levels, which were found in 41.8% of moderately obese individuals and 59.6% of those in the obese category, but less than 5% of those in the underweight category (Po0.001 across BMI categories). Low HDL-C was also observed in over 40% of those in the two highest BMI categories compared with under 10% of those in the underweight categories (Po0.001 across BMI categories). Of particular note was that diabetes prevalence increased from 0.7 to 21.8% across BMI groups. Three-to fourfold differences in these factors were seen when comparing high vs normal WC groups as well. Abbreviations: BMI, body mass index; IDF, International Diabetes Federation; WC, waist circumference. WC: normal p102 cm in men and p88 cm in women (or p90 cm in men and p80 cm in women using the IDF criteria); High 4102 cm in men and 488 cm in women (or 490 cm in men and 480 cm in women using the IDF criteria). Weighted sample size (N) in millions. Po0.001 comparing the BMI and WC distributions across gender, ethnic and age groups.
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There were also ethnic differences in risk factor relationships with BMI and WC groups. Most apparent is the attenuated relation of several risk factors with BMI and/or WC groups in non-Hispanic blacks. Unlike other ethnic groups, both systolic and diastolic blood pressures were as high or nearly as high in non-Hispanic blacks with lower compared with higher levels of BMI and WC. HDL-C, on the other hand, remained high (protective) and triglyceride levels were not substantially elevated when BMI or WC levels were elevated ( . Across ethnic groups, over 50% of those in the moderate obese and obese categories had X3 cardiometabolic risk factors. Non-Hispanic whites had the highest prevalence of five or more cardiometabolic risk factors in the BMI X35 category at 25.0%, followed by Hispanics at 22.0%. With regards to abdominal obesity, Figure 2 illustrates the prevalence of cardiometabolic risk factors within normal and high WC groups by gender and Across categories consisting of those with normal BMI and normal WC, normal BMI and high WC and high BMI regardless of WC, the prevalence of hypertension, low HDL-C, elevated triglycerides, diabetes, elevated C-reactive protein and family history of heart attack have increased consistently. (Po0.05-Po0.001; Figure 3) . . Across ethnic groups, these ORs ranged twofold from 13.4 in nonHispanic blacks to 27.2 in Hispanics. The increased OR of X3 cardiometabolic risk factors associated with increased BMI was attenuated substantially after adjusting for age, gender and WC, and no longer significant except in Hispanics (OR ¼ 5.5, 95% CI ¼ 1.4-21.7). When compared to those with normal WC, those with increased WC were nearly 10 times more likely to have X3 cardiometabolic risk factors (OR ¼ 9.6, 95% CI ¼ 7.9-11.7), with even higher OR seen in non-Hispanic blacks (12.4) and in Hispanics (12.8). Overall, the relation of increased WC with having X3 cardiometabolic risk factors was attenuated, but remained highly significantF5.1 (95% CI ¼ 2.9-6.6) when adjusted for BMI. These BMI-adjusted OR were even higher for non-Hispanic blacks (7.9) and for Hispanics (6.7; Table 3 ). Table 3 ). Figure 4 illustrates the distribution of Framingham risk across BMI obesity groups by gender and ethnicity. Women in the BMI o18.5 group were at the lowest 10-year risk within the next 10 years (92.6% with o6% risk), whereas men in the BMI X35.0 group had the highest risk (over 30% at 420% 10-year risk). In men and women, the proportion with high CVD risk status increased more than threefold from the BMI o18.5 group to the BMI X35.0 group (9.9-32.9 and 7.4-32.9%, respectively, each Po0.001 across BMI groups). Among ethnic groups, despite being in the overweight (nonobese) group, over 40% of non-Hispanic whites had a moderate-to-high risk of CHD. Within the BMI X35.0 category, Non-Hispanic whites also had the highest proportion of those at the highest risk for CVD with 28%, followed by non-Hispanic blacks and Hispanics with 22.9 and 20.1%, respectively (Po0.001). Figure 5 shows the extent of Framingham risk within abdominal obesity groups by gender and ethnicity. Women with normal WC had the lowest risk for CHD with 88.5% in the o6% risk category. Among those with high WC, 27.9% of men, 19.5% of women, 23.9% of non-Hispanic whites, 21.5% of non-Hispanic blacks and 15.8% of Hispanics had a high CVD risk (Po0.001). Also nearly 60% of men in the abdominal obesity group had a moderate or higher risk, compared with just under 30% in women in the same category.
Extent of high global risk of CVD in BMI and WC groups
Discussion
This study has shown the extent to which obesity and abdominal obesity are associated with cardiometabolic risk factors and estimated global risk of CVD in a nationally representative multiethnic U S adult population. Of note, 60% of women and over half of non-Hispanic whites and non-Hispanic blacks are defined to have abdominal obesity. Additionally, using lower IDF-recommended cut points to define abdominal obesity in Hispanics, over three-fourths of this group would fit the definition. Also, nearly half of men, 40% of non-Hispanic whites and close to one-third of nonHispanic blacks and Hispanics who have abdominal obesity are at moderately high or high-risk CVD status.
Most importantly, we show those with high vs normal WC had more than a fivefold increased likelihood of multiple cardiometabolic risk factors and over a 50% greater likelihood of having high CHD risk status, even after adjusting for BMI, suggesting the independence of high WC over and above BMI in identifying high-risk individuals. This finding remained most important in whites, suggesting the utility of 
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H Ghandehari et al WC for identifying high-risk individuals in this ethnic group. The relation of BMI with high-risk status, on the other hand, was completely attenuated after adjustment for WC; only in Hispanics did a high BMI remain predictive of multiple cardiometabolic risk factors after adjusting for BMI, suggesting BMI may be a better marker of cardiovascular risk in Hispanics than in other ethnic groups. Abdominal obesity was also significantly associated with high-risk status of CVD across gender and ethnicity groups. Individuals with high WC who were not considered obese by BMI levels had a higher prevalence of cardiometabolic risk factors such at hypertension and elevated LDL-C than those who were obese. In addition, our study notes an increase in severity of most cardiometabolic risk factors with increasing BMI or WC, although these findings appear attenuated in blacks, where blood pressure, LDL-C, HDL-C, and triglycerides bear a weaker relation with BMI and WC. These findings suggest identification of obesity in blacks may be less effective in identifying other components of metabolic syndrome or cardiovascular risk than in other ethnicities. Hence, this would argue for the need to screen for all components of the metabolic syndrome, rather than relying on the presence of abdominal obesity in addition to two other components as is recommended by the IDF. 4 Several studies have demonstrated the clinical significance of abdominal obesity with respect to CVD risk. In a large study examining over 16 000 men and women from Canada, Reeder and colleagues noted WC, as compared to other anthropometric variables including hip circumference, waist/hip ratio, and body mass index, to bear the strongest correlations with other CVD risk factors, with strongest associations being with triglycerides, and intermediate associations with HDL, systolic and diastolic blood pressure. 11 Of interest is a report from the Framingham Heart Study showing that visceral adipose tissue (as opposed to subcutaneous adipose tissue) measured by multidetector computed tomography was strongly associated with the likelihood of metabolic syndrome and risk factor differences, even after adjusting for BMI and WC. 12 In another report, waist girth and waist hip ratio was associated with subclinical atherosclerosis measured by coronary calcium. 13 Importantly, in a large cohort of 1346 middle-aged Finnish men free of CVD at baseline followed for 10.6 years, waisthip ratio, WC and BMI were all directly associated with the risk of coronary events with waist-hip ratio providing additional information beyond BMI in predicting CHD, whereas BMI did not add to the prediction of CHD over waist-hip ratio. 14 Other studies have primarily focused on BMI as a predictor of CHD and/or all-cause mortality. (160 mg 100 ml À1 ) if o2 risk factors, X3.4 mmol l À1 (130 mg 100 ml À1 ) if X2 risk factors and p20% 10-year risk of coronary heart disease (CHD) and 2.6 mmol l
15-17
À1
(X100 mg 100 ml À1 ) if cardiovascular disease (CVD), diabetes or 420% 10-year risk of CHD; low high-density lipoprotein cholesterol (HDL-C): HDL-C o40 mg 100 ml À1 in men or o50 mg 100 ml À1 in women; high triglycerides: triglycerides X150 mg 100 ml À1 ; high C-reactive protein (CRP): 43 mg l À1 ; smoking: current smoker; family history: any relative had a heart attack before the age of 50. *Po0.05, w Po0.01 z Po0.001 across WC groups; sample sizes varied across risk factors. Abbreviations: BMI, body mass index; CHD, coronary heart disease; CRP, C-reactive protein; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein-cholesterol; WC, waist circumference. WC: normal, p102 cm in men and p88 cm in women; High, 4102 cm in men and 488 cm in women. Risk factors include hypertension, elevated LDL-C or total cholesterol, low HDL-C, elevated triglycerides, diabetes, elevated CRP, abdominal obesity, smoking and family history of heart attack. High CVD risk is defined as 420% of 10-year CHD risk, diabetes or CVD. Figure 4 Framingham risk score category within the body mass (BMI) groups by gender and ethnicity. High-risk category includes those with diabetes or cardiovascular disease (CVD) or 420% 10-year risk of coronary heart disease (CHD). Sample sizes: n ¼ 2031 in men, n ¼ 2100 in women, n ¼ 2215 in non-Hispanic (NH) whites, n ¼ 781 in NH blacks and n ¼ 958 in Hispanics. Po0.001 across BMI groups. .
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This study includes several strengths such as the use of a large, multiethnic survey with sample weights, which allows results to be projected to the US adult population. Analysis of the NHANES 2003-2004 database assured a consistent protocol for the measurements of BMI, WC and other risk factors, including blood pressure and laboratory measures of glucose and lipids. Limitations of this cross-sectional survey include laboratory tests performed on a single visit, which cannot account inherent variability in lipid levels and other similar measurements. Furthermore, the Framingham risk equation was used to project the global risk of CHD as opposed to the use of actual CHD events. Moreover, as it was beyond the scope to examine these relationships separately according to lipid or blood pressure medication usage, some persons with actually normal levels of lipids, blood pressure or C-reactive protein could be normal for these factors from being on medications, such as statins or blood pressure drugs, which would have resulted in the underestimation of risk in these persons. Further, some with known CVD may have lost weight since their diagnosis, and therefore this would also tend to underestimate risk in the higher BMI or WC categories compared with the lower ones. Finally, our WC cut points are based on those recommended by the National Cholesterol Educational Program 5 for the purposes of defining the metabolic syndrome in US adults; thus our findings may be not generalizable to non-US populations where other standards have been proposed. We have, however, also shown results for Hispanics using lower cut points recommended by the IDF. 6 In summary, over half of women, non-Hispanic whites and non-Hispanic blacks have abdominal obesity, and threefourths of Hispanics fit IDF-recommended cut points to define abdominal obesity. Also, men and non-Hispanic whites with abdominal obesity tend to be more likely to be at moderately high or high-risk CVD status. Furthermore, the association of increased WC to multiple cardiometabolic risk factors and high CVD risk status is independent of BMI, validating WC to be an important measure that should be widely implemented in initial assessment of patients in the primary care setting. Further investigation is required to document prospectively whether these relationships hold for the prediction of future diabetes onset, cardiovascular events or mortality in the US adult population. 
Abdominal obesity and global risk
H Ghandehari et al
